MIG
ATRS

Mariner Investment Group’s Antares Pharma, Inc. ATRS Stock Holding History

Mariner Investment Group’s Portfolio ATRS Stock Details ATRS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q2 		– Sell
-281,477
Closed -$763K – 245
2015
Q1 		$763K Hold
281,477
– – 0.2% 106
2014
Q4 		$723K Hold
281,477
– – 0.12% 145
2014
Q3 		$515K Sell
281,477
-15,000
-5% -$32.7K 0.11% 139
2014
Q2 		$792K Hold
296,477
– – 0.15% 119
2014
Q1 		$1.04M Buy
+296,477
New +$1.32M 0.23% 91

Other funds holding ATRS

DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
BC
Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
GPP
Great Point Partners Greenwich, Connecticut $435M AUM 318.81% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
KCM
Kingdon Capital Management New York $911M AUM 51.11% 1-Year Est. Return
WHI
William Harris Investors Chicago, Illinois $347M AUM 3.53% 1-Year Est. Return

Mariner Investment Group's ATRS Position: Q2 2015 in Review

Mariner Investment Group sold out of Antares Pharma, Inc. (ATRS) in Q2 2015, closing a stake of 281,477 shares — an estimated $763K sold.

Mariner Investment Group first reported a position in ATRS in Q1 2014 and held it in 5 quarters. The position peaked at $1.04M in Q1 2014. 88 funds tracked by Wall St. Rank hold ATRS as of Q2 2015.

  • Mariner Investment Group reported no remaining Antares Pharma, Inc. position as of Q2 2015 after selling out during the quarter.
  • Mariner Investment Group sold 281,477 Antares Pharma, Inc. shares in Q2 2015, an estimated $763K.
  • Mariner Investment Group first reported a position in Antares Pharma, Inc. in Q1 2014 and held it in 5 quarters.
  • Mariner Investment Group's Antares Pharma, Inc. position peaked at $1.04M in Q1 2014.
  • 88 funds tracked by Wall St. Rank held Antares Pharma, Inc. as of Q2 2015.

Based on Mariner Investment Group's 13F filing for Q2 2015, filed 14 Aug 2015.